Creative Planning cut its stake in PetIQ Inc (NASDAQ:PETQ) by 34.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,730 shares of the company’s stock after selling 5,060 shares during the period. Creative Planning’s holdings in PetIQ were worth $244,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Gabelli Funds LLC raised its stake in shares of PetIQ by 12.4% in the third quarter. Gabelli Funds LLC now owns 313,500 shares of the company’s stock worth $8,546,000 after acquiring an additional 34,500 shares during the last quarter. Occidental Asset Management LLC raised its stake in shares of PetIQ by 23.9% in the fourth quarter. Occidental Asset Management LLC now owns 57,000 shares of the company’s stock worth $1,428,000 after acquiring an additional 11,000 shares during the last quarter. State Street Corp raised its stake in shares of PetIQ by 2.5% in the third quarter. State Street Corp now owns 439,235 shares of the company’s stock worth $11,974,000 after acquiring an additional 10,564 shares during the last quarter. Envestnet Asset Management Inc. raised its stake in shares of PetIQ by 2.6% in the third quarter. Envestnet Asset Management Inc. now owns 28,163 shares of the company’s stock worth $768,000 after acquiring an additional 709 shares during the last quarter. Finally, California Public Employees Retirement System bought a new position in shares of PetIQ in the third quarter worth about $930,000. 99.74% of the stock is owned by institutional investors.

PETQ opened at $34.28 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.67 and a quick ratio of 1.45. The company has a market cap of $965.21 million, a price-to-earnings ratio of -190.44, a price-to-earnings-growth ratio of 0.94 and a beta of 1.89. The firm has a 50 day simple moving average of $28.74 and a 200 day simple moving average of $27.60. PetIQ Inc has a fifty-two week low of $21.28 and a fifty-two week high of $36.33.

A number of equities analysts have weighed in on the stock. Zacks Investment Research raised shares of PetIQ from a “sell” rating to a “hold” rating in a research note on Wednesday, January 8th. BidaskClub raised shares of PetIQ from a “sell” rating to a “hold” rating in a research note on Tuesday, January 14th. Finally, Raymond James reissued a “buy” rating on shares of PetIQ in a research note on Wednesday, December 4th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $36.67.

In related news, EVP Will Santana sold 17,500 shares of the business’s stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $30.61, for a total transaction of $535,675.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 23.79% of the company’s stock.

About PetIQ

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

Featured Story: Closed-End Mutual Funds

Institutional Ownership by Quarter for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.